MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-06-05 for HEPARIN SYRINGE manufactured by Becton Dickinson And Company.
[110337160]
Serratia marcescens bacteremia. Pt had central vascular access catheter that was being maintained with heparin. Product used for maintaining line included bd heparin syringe that was part of a voluntary recall for serratia marcescens. Dose or amount: 5 ml millilitre(s), daily, intravenous. Therapy start date: (b)(6) 2018; therapy end date: (b)(6) 2018.
Patient Sequence No: 1, Text Type: D, B5
Report Number | MW5077643 |
MDR Report Key | 7572915 |
Date Received | 2018-06-05 |
Date of Report | 2018-06-04 |
Date of Event | 2018-05-05 |
Date Added to Maude | 2018-06-06 |
Event Key | 0 |
Report Source Code | Voluntary report |
Manufacturer Link | N |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Reporter Occupation | OTHER HEALTH CARE PROFESSIONAL |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 0 |
Brand Name | HEPARIN SYRINGE |
Generic Name | HEPARIN, VASCULAR ACCESS FLUSH |
Product Code | NZW |
Date Received | 2018-06-05 |
Device Availability | N |
Device Eval'ed by Mfgr | I |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | BECTON DICKINSON AND COMPANY |
Manufacturer Address | COLUMBUS NE US |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Hospitalization | 2018-06-05 |